BRAGAZZI, MARIA CONSIGLIA
 Distribuzione geografica
Continente #
NA - Nord America 3.314
EU - Europa 1.443
AS - Asia 473
AF - Africa 21
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.270
Nazione #
US - Stati Uniti d'America 3.280
IT - Italia 722
IE - Irlanda 277
IN - India 166
SG - Singapore 156
CN - Cina 140
SE - Svezia 127
FI - Finlandia 83
GB - Regno Unito 57
BG - Bulgaria 36
DE - Germania 35
FR - Francia 31
CA - Canada 29
UA - Ucraina 29
RO - Romania 12
TG - Togo 11
AR - Argentina 9
CH - Svizzera 9
CZ - Repubblica Ceca 5
HR - Croazia 5
NL - Olanda 5
BE - Belgio 3
BR - Brasile 3
ID - Indonesia 3
KE - Kenya 3
ZA - Sudafrica 3
AU - Australia 2
EG - Egitto 2
HU - Ungheria 2
MX - Messico 2
RU - Federazione Russa 2
TR - Turchia 2
AP - ???statistics.table.value.countryCode.AP??? 1
BJ - Benin 1
BO - Bolivia 1
BZ - Belize 1
CL - Cile 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
LI - Liechtenstein 1
PH - Filippine 1
PL - Polonia 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 5.270
Città #
Fairfield 617
Dublin 274
Woodbridge 274
Ashburn 236
Seattle 232
Chandler 213
Cambridge 190
Rome 190
Houston 189
Wilmington 170
Princeton 100
Beijing 99
Ann Arbor 97
Singapore 81
Fremont 69
Plano 67
Dearborn 53
San Paolo di Civitate 48
Lawrence 47
Helsinki 46
Boston 43
San Diego 43
Millbury 36
Sofia 35
Milan 29
London 28
New York 25
Des Moines 23
Phoenix 21
Nanterre 20
Andover 18
Ottawa 18
Norwalk 14
Bologna 13
Piscataway 12
Southend 12
Lomé 11
Naples 11
San Mateo 10
Falls Church 9
Federal 9
Redwood City 9
Toronto 9
Padova 8
Princeton Junction 8
San Nicola la Strada 8
Bangalore 7
Bühl 7
Florence 7
Mannheim 7
Palermo 7
Catania 6
Guangzhou 6
Iesi 6
Jacksonville 6
Kunming 6
Livorno 6
Orem 6
Genova 5
Grossalmerode 5
Nanjing 5
Zagreb 5
Beinasco 4
Bremen 4
Pontedera 4
Sesto San Giovanni 4
Verona 4
Zurich 4
Boardman 3
Bolzano Vicentino 3
Caldwell 3
Colle Di Val D'elsa 3
Formigine 3
Hefei 3
Hostivice 3
Los Angeles 3
Mascalucia 3
Paris 3
Pavia 3
Pune 3
San Giovanni Lupatoto 3
Settimo Torinese 3
São Paulo 3
Triggiano 3
Azzate 2
Bandung 2
Benevento 2
Bentivoglio 2
Budapest 2
Bussolengo 2
Cairo 2
Calcio 2
Caltagirone 2
Campi Bisenzio 2
Castel San Lorenzo 2
Castello di Godego 2
Changsha 2
Ciampino 2
Città di Castello 2
Columbus 2
Totale 3.975
Nome #
FXR modulators and cholestatic diseases | [Modulatori di FXR e patologie colestatiche] 189
Poliprotect vs omeprazole in the relief of heartburn, epigastric pain and burning in patients without erosive esophagitis and gastro-duodenal lesions. A randomized, controlled trial 176
Italian clinical practice guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 138
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma 117
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 115
Profiles of cancer stem cell subpopulations in cholangiocarcinomas 114
Transplantation of stem/progenitor cells isolated from human fetal biliary tree into two patients with advanced liver cirrhosis 110
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples 107
547 CHOLANGIOCARCINOMA IN ITALY: A NATIONAL SURVEY ON DEMOGRAPHIC AND CLINICAL CHARACTERISTICS, DIAGNOSTIC MODALITIES AND TREATMENT 101
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA response score 97
Italian practical clinical guidelines on cholangiocarcinoma: Part II, treatment 96
Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images 93
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics 91
Intrahepatic cholangiocarcinoma: review and update 90
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines 84
Atorvastatin-Induced Prolonged Cholestasis with Bile Duct Damage 82
Comprehensive characterization of cancer driver genes and mutations 82
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 82
Cholangiocarcinoma: Update and future perspectives 79
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas 79
New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin 78
Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. 78
Cholangiocytes: Cell transplantation 75
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas 74
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers 73
Cholangiocarcinoma: increasing burden of classifications 72
Polycystins play a key role in the modulation of cholangiocyte proliferation 71
Descriptive epidemiology of cholangiocarcinoma in Italy. 71
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context 70
null 68
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers 67
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma 67
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 66
Biliary insulin like growth factor-1 (IGF1) is a sensitive marker for the diagnosis of extrahepatic cholangiocarcinoma 66
null 64
Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma 63
null 62
Human Leukocyte Antigen Polymorphisms in Italian Primary Biliary Cirrhosis: A Multicenter Study of 664 Patients and 1992 Healthy Controls 62
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 61
Estrogens stimulate the growth of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor (VEGF) 60
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells 59
Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis 58
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 57
HUMAN CHOLANGIOCARCINOMA (CCA) AND CCA CANCER STEM CELLS (CSCS) ARE HIGHLY SENSITIVE TO THE ANTIPROLIFERATIVE EFFECTS OF PI3-KINASE INHIBITORS 57
TUMORIGENIC POTENTIAL OF CANCER STEM CELLS (CSCS) ISOLATED FROM HUMAN CHOLANGIOCARCINOMA (CCA) SUBTYPES IN CIRRHOTIC LIVER 57
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas 56
null 56
Characterization of Cancer Stem Cells in Human Cholangiocarcinoma (CCA) subtypes 56
Estrogens stimulate the growth of human cholangiocarcinoma by activating the vascular endothelial growth factor (VEGF) system 55
Systematic Analysis of Splice-Site-Creating Mutations in Cancer 54
Biliary insulin like growth factor-1 (IGF1) is a sensitive marker for the diagnosis of extrahepatic cholangiocarcinoma 54
null 54
null 53
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas 52
VEGF plays a major role in mediating estrogens proliferative effects on human intrahepatic cholangiocarcinoma 51
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types 51
Cholangiocarcinoma: increasing burden of classifications. 51
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 51
null 50
An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs 49
Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types 48
Erratum: The Immune Landscape of Cancer (Immunity (2018) 48(4) (812–830.e14), (S1074761318301213), (10.1016/j.immuni.2018.03.023)) 47
Tumorigenic potential of cancer stem cells (CSCs) isolated from human cholangiocarcinoma (CCA) subtypes in cirrhotic microenvironment 45
Cholangiocarcinoma: epidemiology and risk factors. 44
TGF-beta signaling is an effective target to block proliferation and induce apoptosis of human cholangiocarcinoma (CCA) cells: a study on human primary cell cultures 44
547 CHOLANGIOCARCINOMA IN ITALY: A NATIONAL SURVEY ON DEMOGRAPHIC AND CLINICAL CHARACTERISTICS, DIAGNOSTIC MODALITIES AND TREATMNET 43
Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor (VEGF) 42
Inflammatory and neoplastic cholangiopathies [Colangiopatie infiammatorie e neoplastiche] 38
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 37
SARCOIDOSIS AND COELIAC DEASEAS: DO NOT FORGET THE ASSOTIATION ! 35
Erratum: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (Cell Reports (2017) 18(11) (2780–2794) (S2211124717302140) (10.1016/j.celrep.2017.02.033)) 34
Erratum: The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (Cell Reports (2018) 23(1) (313–326.e5) (S2211124718304364) (10.1016/j.celrep.2018.03.075)) 34
null 33
De morbo gallico omnia quae extant apud omnes medicos cuiuscunque nationis: the sixteenth-century collection of Luigi Luigini 33
Sensitivity of human cholangiocarcinoma (CCA) cells and CCA cancer stem cells (CSCs) to chemotherapeutics and molecular targeted agents 31
Insulin like growth factor-1 (IGF1) expression and its role in the diagnosis of extrahepatic cholangiocarcinoma. 30
null 30
The spanish influenza pandemic: a lesson from history 100 years after 1918 30
Evidence-based management of primary liver cancers: cholangiocarcinoma [Gestione dei tumori primitivi del fegato basata sull’evidenza: colangiocarcinoma] 28
Sensitivity of human intrahepatic cholangiocarcinoma subtypes to chemotherapeutics and molecular targeted agents: A study on primary cell cultures 26
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 26
Metformin reduces cell migration and down-regulates epithelial to mesenchymal transition (EMT) by AMPK/Foxo3a pathway in human intrahepatic cholangiocarcinoma (CCA) 26
HELICOBACTER PYLORI IN IMMIGRANTS: A FOREIGN BACTRIUM? 19
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers 18
TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures 18
Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment 17
null 17
New Insight into Epidemiology of Cholangicarcinoma 17
Metformin arrests the proliferation, enhances apoptosis and down-regulates epithelial to mesenchymal transition (EMT) in human cholangiocarcinoma (CCA): a study on human primary cell cultures 13
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 11
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 10
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 9
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas 8
TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: a study on human primary cell cultures 7
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients 6
The Immune Landscape of Cancer 4
Role of the Gut-Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical Evidence 3
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer 3
Primary biliary cholangitis: perception and expectation of illness 2
Genomic and Functional Approaches to Understanding Cancer Aneuploidy 2
Totale 5.539
Categoria #
all - tutte 14.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.083 140 46 9 46 102 147 147 119 119 101 67 40
2020/2021598 33 33 36 35 45 107 4 36 70 128 57 14
2021/2022878 44 36 95 37 107 41 21 107 66 49 117 158
2022/20231.154 177 165 41 64 60 93 32 63 347 31 29 52
2023/2024896 50 84 60 76 104 140 62 88 11 82 91 48
2024/202541 41 0 0 0 0 0 0 0 0 0 0 0
Totale 5.541